SE416467B - Sett att framstella nya kinolinderivat med farmakologisk verkan - Google Patents

Sett att framstella nya kinolinderivat med farmakologisk verkan

Info

Publication number
SE416467B
SE416467B SE7301634A SE7301634A SE416467B SE 416467 B SE416467 B SE 416467B SE 7301634 A SE7301634 A SE 7301634A SE 7301634 A SE7301634 A SE 7301634A SE 416467 B SE416467 B SE 416467B
Authority
SE
Sweden
Prior art keywords
want
pharmacological effect
make new
chinoline derivatives
chinoline
Prior art date
Application number
SE7301634A
Other languages
English (en)
Swedish (sv)
Inventor
T A C Boschman
J G Korsloot
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL7201675A external-priority patent/NL7201675A/xx
Priority claimed from NL7215366A external-priority patent/NL7215366A/xx
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of SE416467B publication Critical patent/SE416467B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7301634A 1972-02-09 1973-02-06 Sett att framstella nya kinolinderivat med farmakologisk verkan SE416467B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL7201675A NL7201675A (xx) 1972-02-09 1972-02-09
NL7215366A NL7215366A (en) 1972-11-14 1972-11-14 P-dioxino(2,3-g)quinolines - diuretics, saluretics and hypotensives

Publications (1)

Publication Number Publication Date
SE416467B true SE416467B (sv) 1981-01-05

Family

ID=26644729

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7301634A SE416467B (sv) 1972-02-09 1973-02-06 Sett att framstella nya kinolinderivat med farmakologisk verkan

Country Status (16)

Country Link
US (1) US3865832A (xx)
JP (1) JPS5727112B2 (xx)
AR (1) AR211510A1 (xx)
AT (1) AT323740B (xx)
BE (1) BE795265A (xx)
CA (1) CA1000279A (xx)
CH (1) CH593285A5 (xx)
DE (1) DE2303496A1 (xx)
DK (1) DK138120B (xx)
ES (1) ES411374A1 (xx)
FI (1) FI55847C (xx)
FR (1) FR2181708B1 (xx)
GB (1) GB1366834A (xx)
IL (1) IL41471A (xx)
PH (1) PH14448A (xx)
SE (1) SE416467B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036962A (en) * 1974-08-12 1977-07-19 E. I. Du Pont De Nemours And Co. 6,7-Methylenedioxy-1-(2,2,2-trifluoroethyl)-4(1H)-quinolone-3-carboxylic acid and its salts and esters
US4179506A (en) * 1978-11-13 1979-12-18 Warner-Lambert Company New pyridobenzodioxin compounds and methods for their production
FR2846327B1 (fr) * 2002-10-25 2006-03-24 Merck Sante Sas Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant.
DK2413693T3 (en) * 2009-03-30 2015-11-16 Vtv Therapeutics Llc Substituted azoanthracenderivater, pharmaceutical compositions and methods for use thereof
CN113717185B (zh) * 2021-08-19 2023-04-11 云南省烟草农业科学研究院 雪茄烟根茎中一种具有抗菌活性的喹啉生物碱化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3178348A (en) * 1961-02-08 1965-04-13 Norwich Pharma Co Hypotensive quinolines
GB1076828A (en) * 1963-12-12 1967-07-26 Warner Lambert Pharmaceutical Methylenedioxy quinoline derivatives
DE1908548A1 (de) * 1968-02-29 1970-11-05 Warner Lambert Co Chinolinderivate
CA942310A (en) * 1969-07-09 1974-02-19 Mitsuo Nakashita Preparation of n-substituted 6,7-methylenedioxy-4-quinolone derivatives
DE2030899A1 (de) * 1970-06-18 1971-12-23 Schering Ag, 1000 Berlin Und 4619 Bergkamen Chinolincarbonsäurederivate

Also Published As

Publication number Publication date
FI55847B (fi) 1979-06-29
DK138120B (da) 1978-07-17
DK138120C (xx) 1978-12-04
PH14448A (en) 1981-07-23
FR2181708A1 (xx) 1973-12-07
IL41471A0 (en) 1973-04-30
FR2181708B1 (xx) 1975-10-10
ES411374A1 (es) 1976-07-01
AT323740B (de) 1975-07-25
DE2303496A1 (de) 1973-08-23
FI55847C (fi) 1979-10-10
CA1000279A (en) 1976-11-23
AR211510A1 (es) 1978-01-30
JPS4886896A (xx) 1973-11-15
BE795265A (fr) 1973-08-09
JPS5727112B2 (xx) 1982-06-08
IL41471A (en) 1975-12-31
US3865832A (en) 1975-02-11
GB1366834A (en) 1974-09-11
CH593285A5 (xx) 1977-11-30

Similar Documents

Publication Publication Date Title
SE417204B (sv) Sett att framstella nya kinoxalin- och kinazolinderivat
SE405115B (sv) Sett att framstella nya fenyl-imidazolyl-alkanylderivat med antimykotisk verkan
SE7614680L (sv) Sett att framstella nya bensodiazepinderivat
SE421615B (sv) Sett att framstella nya tiazolderivat
SE397520B (sv) Sett att framstella nya nonapeptidamidderivat med ovulationsinducerande aktivitet
SE430502B (sv) Sett att framstella nya substituerade imidazolidiner
SE7508101L (sv) Sett att framstella nya kinazolinderivat med terapeutisk verkan.
SE419161B (sv) Sett att framstella nya tabletter, innehallande mikrokapslar i massan med forlengd verkan
SE7711848L (sv) Sett att framstella nya 5-metyl-7-hydroxi-isoflavonderivat
SE411349B (sv) Sett att framstella nya penicilliner
SE412586B (sv) Sett att framstella isoflavonderivat
SE421690B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE410600B (sv) Sett att framstella nya arylaminopyrimidinderivat
SE397830B (sv) Sett att framstella nya bensodioxol-piperazinderivat
SE405477B (sv) Forfarande for framstellning av tetrazolyl-kinaldinsyraderivat med farmakologisk verkan
SE391181B (sv) Sett att framstella kinazolinderivat
SE397976B (sv) Nya kinoxalin-di-n-oxider med tillvextbefordrande verkan
SE391337B (sv) Sett att framstella 2-substituerade adenosinderivat
SE384867B (sv) Sett att framstella 2-substituerade adenosinderivat
SE405851B (sv) Forfarande for framstellning av nya 2-aminometylenindanoner med analgetisk verkan
SE386164B (sv) Sett att framstella nya 2-alkylamino-dihydropyridiner
SE420087B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE416467B (sv) Sett att framstella nya kinolinderivat med farmakologisk verkan
SE415564B (sv) Sett att framstella nya cefalosporinderivat
SE413022B (sv) Sett att framstella nya propylendiaminderivat